Biological E collaborate with Bavarian Nordic to expand Chikungunya Vaccine access in low, middle income countries Ruchika Sharma1 March 2025 10:00 AM ISTHyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian Nordic's Chikungunya...
Bharat Biotech, Biological E among 11 companies to invest Rs 5,445 crore in Green Pharma City Ruchika Sharma28 Feb 2025 11:05 PM ISTHyderabad: 11 companies including Bharat Biotech, Biological E committed to invest Rs 5,445 crore in the Green Pharma City. The...
Biological E Gets CDSCO Panel Nod To Study Inactivated Poliomyelitis Vaccine Dr. Divya Colin16 Feb 2025 6:00 PM ISTNew Delhi: Vaccine major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications Farhat Nasim20 Dec 2024 6:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...
Revise protocol for conducting Phase I CT in India: CDSCO Panel Tells Biological E on Typhoid and Paratyphoid A Bivalent Vaccine Dr. Divya Colin9 Dec 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I clinical trial report of Typhoid and Paratyphoid A Bivalent Vaccine conducted in Europe, the Subject Expert...
CDSCO Panel approves Biological E's Phase IV clinical trial protocol to study PNEUBEVAX-14 Dr. Divya Colin27 Oct 2024 5:30 PM ISTNew Delhi: The vaccine major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Biological E gets permission for COVID-19 Vaccine SARSCoV-2-RBD203-N1_XBB.1.5 for restricted use in emergency Dr. Divya Colin7 Sept 2024 6:00 PM ISTNew Delhi: Recommending for strain change/update in the approved COVID-19 vaccine, the Subject Expert Committee (SEC) functional under the Central...
Increase sample size for immunogenicity analysis for booster dose: CDSCO Panel Tells Biological E on PCV-14 Vaccine Dr. Divya Colin18 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the amended Phase IV clinical trial protocol of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14-valent) [PCV-14]...
Biological E gets WHO pre-qualification status for oral polio vaccine Ruchika Sharma31 July 2024 11:38 AM IST Hyderabad: In a stride towards eradicating polio worldwide, Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company has...
Submit complete Phase-I CT report: CDSCO Panel Tells Biological E on Bivalent Typhoid and Paratyphoid A Conjugate Vaccine Dr. Divya Colin23 July 2024 6:00 PM ISTNew Delhi: Reviewing the interim Phase-I clinical trial report of Typhoid and Paratyphoid A Conjugate Vaccine Bivalent, the Subject Expert Committee...
CDSCO panel noted Biological E's Post Marketing Surveillance Report of Monovalent recombinant Hepatitis-B vaccine Dr. Divya Colin18 May 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has noted the post-marketing...
Biological E Gets CDSCO Panel Nod for Continued Safety study of 14-valent pneumococcal polysaccharide conjugate vaccine Dr. Divya Colin7 May 2024 6:00 PM ISTNew Delhi: The drug major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
